Hamzei Analytics Financial Network

Our mission is to provide valuable trading insights to advanced traders for analysis of mass behavior in the equity, bond, commodity and currency markets.

Showing posts with label FDA. Show all posts
Showing posts with label FDA. Show all posts
Wednesday, September 19, 2007

Pink slips at the FDA will equate to red ink for biotech investors

›
David Miller Andy von Eschenbach, FDA Commissioner, says he’ll have to issue 2,000 60-day pink slips at the FDA if Congress and the Presiden...
›
Home
View web version
Powered by Blogger.